Copyright
©The Author(s) 2016.
World J Gastroenterol. Oct 7, 2016; 22(37): 8382-8388
Published online Oct 7, 2016. doi: 10.3748/wjg.v22.i37.8382
Published online Oct 7, 2016. doi: 10.3748/wjg.v22.i37.8382
Table 1 Clinical characteristics and laboratory data of enrolled patients
Age≥80 yr | Age < 80 yr | P value | |
(n = 102) | (n = 105) | ||
Age (yr) | 85 (81-92) | 67 (58-75) | < 0.05 |
Sex | |||
Male | 41 (40.2) | 62 (59.0) | < 0.05 |
Female | 61 (59.8) | 43 (41.0) | |
Fever (centigrade) | 39.0 (38.5-39.3) | 38.9 (38.7-39.4) | NS |
WBC (103/L) | 12.8 (10.4-15.2) | 12.5 (10.7-14.6) | NS |
Platelet (103/L) | 132 (105-180) | 171 (130-231) | < 0.05 |
Albumin (g/dL) | 2.9 (2.6-3.3) | 3.6 (3.4-4.0) | < 0.05 |
Bilirubin (mg/dL) | 4.3 (3.1-6.0) | 4.2 (2.8-6.7) | NS |
AST (U/L) | 229 (150-418) | 182 (141-256) | < 0.05 |
ALT (U/L) | 195 (128-277) | 197 (144-303) | NS |
ALP (U/L) | 798 (576-1154) | 811 (510-1175) | NS |
γ-GTP (U/L) | 336 (256-451) | 350 (249-548) | NS |
ASA | |||
Class 2 | 34 (33.3) | 59 (56.2) | < 0.05 |
Class 3 | 67 (65.7) | 45 (42.9) | |
Class 4 | 1 (1.0) | 1 (1.0) |
Table 2 Comorbidities of patients with acute cholangitis n (%)
Age≥80 yr | Age < 80 yr | P value | |
(n = 102) | (n = 105) | ||
Comorbidity | 93 (91.2) | 71 (67.6) | < 0.05 |
Hypertension | 80 (78.4) | 53 (50.5) | < 0.05 |
Ischemic heart disease | 40 (39.2) | 18 (17.1) | < 0.05 |
Chronic heart failure | 8 (7.8) | 6 (5.7) | NS |
Arrhythmia | 17 (16.7) | 14 (13.3) | NS |
Cerebrovascular disease | 30 (29.4) | 10 (9.5) | < 0.05 |
Dementia | 23 (22.5) | 4 (3.8) | < 0.05 |
Diabetes mellitus | 21 (20.6) | 19 (18.1) | NS |
Chronic liver disease | 9 (8.8) | 8 (7.6) | NS |
Liver cirrhosis | 3 (2.9) | 3 (2.9) | NS |
COPD/Asthma | 15 (14.7) | 7 (6.7) | < 0.05 |
Chronic renal failure | 5 (4.9) | 4 (3.8) | NS |
Malignancy1 | 8 (7.8) | 3 (2.9) | < 0.05 |
Periampullary diverticulum | 25 (24.5) | 14 (13.3) | < 0.05 |
Table 3 Etiology of acute cholangitis n (%)
Age≥80 yr | Age < 80 yr | P value | |
(n = 102) | (n = 105) | ||
CBD stone | 65 (63.7) | 72 (68.6) | NS |
Gallstone cholecystitis | 2 (2.0) | 4 (3.8) | NS |
Pancreatitis | 1 (1.0) | 2 (1.9) | NS |
Malignant obstruction | 31 (30.4) | 23 (21.9) | < 0.05 |
Pancreatic cancer | 4 (3.9) | 5 (4.8) | NS |
Biliary cancer | 21 (20.6) | 11 (10.5) | < 0.05 |
GB cancer | 3 (2.9) | 4 (3.8) | NS |
Other cause1 | 3 (2.9) | 3 (2.9) | NS |
Benign stricture | 3 (2.9) | 4 (3.8) | NS |
Table 4 Procedural details of endoscopic retrograde cholangiopancreatography n (%)
Age ≥ 80 yr | Age < 80 yr | P value | |
(n = 102) | (n = 105) | ||
Details of the procedure | |||
Biliary stent insertion | 97 (95.1) | 100 (95.2) | NS |
Endoscopic sphincterotomy | 69 (67.6) | 87 (82.9) | < 0.05 |
Complete stone removal | 53/651 (81.5) | 67/722 (93.1) | < 0.05 |
Technical success3 | 97 (95.1) | 100 (95.2) | NS |
Procedures time (min), mean ± SD | 37.6 ± 8.1 | 40.1 ± 7.7 | NS |
Failed cannulation | 5 (4.9) | 5 (4.8) | NS |
Table 5 Endoscopic retrograde cholangiopancreatography-related complications n (%)
Age ≥ 80 yr | Age < 80 yr | P value | |
(n = 102) | (n = 105) | ||
Total | 7 (6.9) | 7 (6.7) | NS |
Bleeding after EST | 3 (2.9) | 2 (1.9) | NS |
Post-ERCP pancreatitis | 1 (1.0) | 4 (3.8) | < 0.05 |
Aggravation of cholangitis | 2 (2.0) | 1 (1.0) | NS |
Aspiration pneumonia | 1 (1.0) | 1 (1.0) | NS |
Mortality | 0 | 0 | NA |
Table 6 Cardiorespiratory suppression during endoscopic retrograde cholangiopancreatography under moderate sedation n (%)
Age≥80 yr | Age < 80 yr | P value | |
(n = 102) | (n = 105) | ||
Total | 9 (8.8) | 8 (7.6) | NS |
Hypoxemia | 2 (2.0) | 2 (1.9) | NS |
Bradycardia | 4 (3.9) | 4 (3.8) | NS |
Hypotension | 5 (4.9) | 4 (3.8) | NS |
- Citation: Tohda G, Ohtani M, Dochin M. Efficacy and safety of emergency endoscopic retrograde cholangiopancreatography for acute cholangitis in the elderly. World J Gastroenterol 2016; 22(37): 8382-8388
- URL: https://www.wjgnet.com/1007-9327/full/v22/i37/8382.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i37.8382